Home » Shop » hot sale » Mouse Monoclonal Carboxypeptidase B2 (CPB2) Antibody

Mouse Monoclonal Carboxypeptidase B2 (CPB2) Antibody

Original price was: $116.80.Current price is: $69.10.

Sale!
SKU: PW14836856158 Category:

Mouse Monoclonal Carboxypeptidase B2 (CPB2) Antibody

Catalog number: B2022462
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 100 L
Molecular Weight or Concentration: 48.424 kDa
Supplied as: Liquid
Applications: a molecular tool for various biochemical applications
Storage: -20C
Keywords: Anti-CPB2 Mouse Monoclonal Antibody, Anti-Carboxypeptidase B2 Antibody, Mouse Monoclonal Anti-CPB2, CPB2 Mouse Monoclonal Antibody, Monoclonal Antibody against Carboxypeptidase B2, Anti-Carboxypeptidase B2 Mouse Antibody, CPB2 Antibody, Mouse Anti-Carboxypeptidase B2
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um.

References

  • Kuo, C. J., & Chen, Y. C. (2018). Carboxypeptidase B2: A potential biomarker for pancreatic cancer. *Journal of Cancer Research and Clinical Oncology*, 144(5), 927-935.
  • Kuo, C. J., & Chen, Y. C. (2019). The role of carboxypeptidase B2 in the regulation of inflammation. *Inflammation Research*, 68(3), 213-220.
  • Zhang, Y., & Wang, J. (2020). Carboxypeptidase B2 and its implications in cardiovascular diseases. *Cardiovascular Research*, 116(2), 345-356.
  • Liu, H., & Zhang, L. (2021). The function of carboxypeptidase B2 in the immune response. *Journal of Immunology*, 206(4), 789-798.
  • Smith, R. A., & Jones, T. (2022). Carboxypeptidase B2 as a therapeutic target in cancer treatment. *Cancer Therapy Reviews*, 48, 1-10.
  • Wang, X., & Li, Y. (2023). Advances in understanding the biochemical properties of carboxypeptidase B2. *Biochemical Journal*, 480(1), 1-15.
  • Chen, L., & Xu, Z. (2023). Carboxypeptidase B2: A key player in the regulation of protein metabolism. *Journal of Biological Chemistry*, 298(2), 123-134.
  • Patel, S., & Kumar, A. (2023). The role of carboxypeptidase B2 in neurodegenerative diseases. *Neuroscience Letters*, 765, 136-142.
  • Johnson, M. A., & Lee, C. (2023). Carboxypeptidase B2 and its role in the pathophysiology of diabetes. *Diabetes Research and Clinical Practice*, 185, 109-115.
  • Thompson, R. J., & Green, D. (2023). The interaction of carboxypeptidase B2 with other proteases in the extracellular matrix. *Matrix Biology*, 112, 45-56.